Cellino Biotech, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2017

Location

Cambridge MA US

Primary Industry

Biotechnology

About

Based in Massachusetts, US, and founded in 2017, Cellino Biotech, Inc. is a company that utilizes intracellular delivery lasers and nanotechnology for gene editing applications. The company's platform automates stem cell production using image-guided machine learning, single-cell laser processing, and robotics. The company develops an automated process to generate autologous induced pluripotent stem cells (iPSCs) at scale. Cellino was founded by its CEO Nabiha Saklayen and is backed by investors including Khosla Ventures, 8VC, The Engine, and Humboldt Fund. Following the funding from Khosla Ventures and The Engine, Cellino Biotech Inc plans to automate and scale its transformative AI-based personalized tissue and cell platform.

Current Investors

Khosla Ventures, Engine Ventures, 8VC

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy

Website

www.cellinobio.com

Verticals

Artificial Intelligence, Manufacturing, Nanotechnology, Robotics

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.